RT Journal
A1 Cooper JR
T1 MEthadone treatment and acquired immunodeficiency syndrome
JF JAMA
JO JAMA
YR 1989
FD September 22
VO 262
IS 12
SP 1664
OP 1668
DO 10.1001/jama.1989.03430120118033
UL http://dx.doi.org/10.1001/jama.1989.03430120118033
AB In light of the recent growth in public financial support for the rapid expansion of drug abuse treatment capacity, the unique effectiveness of methadone hydrochloride treatment in reducing intravenous opioid abuse and the associated sharing of injection equipment is reviewed and discussed, and its potential effect on preventing the spread of acquired immunodeficiency syndrome is examined. In addition to methadone, treatment variables that clinical research suggests are integral to effective treatment are identified. Methadone treatment is one of the most helpful means of reducing the risk of acquired immunodeficiency syndrome available, provided that programs of quality are expanded. The medical profession and universities are urged to take steps to ensure quality efforts in prevention and treatment.(JAMA. 1989;262:1664-1668)